Coventry University Featured PhD Programmes
Imperial College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes
"nhs"×
10 miles

Biochemistry (nhs) PhD Projects, Programs & Scholarships

We have 16 Biochemistry (nhs) PhD Projects, Programs & Scholarships

  • "nhs" ×
  • Biochemistry×
  • clear all
Order by 
Showing 1 to 10 of 16
  (MRC DTP) Understanding the regulation of an IL-1alpha inflammatory reaction
  Dr D Brough, Prof S Allan, Dr J Rivers-Auty
Application Deadline: 15 November 2019

Funding Type

PhD Type

Background. Inflammation is a response of the innate immune system that controls infection and promotes resistance and tissue repair.
  EPSRC Centre for Doctoral Training (CDT) in Smart Medical Imaging

Funding Type

PhD Type

The new EPSRC Centre for Doctoral Training (CDT) in Smart Medical Imaging at King's College London and Imperial College London continues the successful…
  EPSRC Centre for Doctoral Training (CDT) in Smart Medical Imaging

Funding Type

PhD Type

The new EPSRC Centre for Doctoral Training (CDT) in Smart Medical Imaging at King's College London and Imperial College London continues the successful…
  Exploring treatment resistance in mantle cell lymphoma
  Dr C Hutchinson, Prof S Rule
Application Deadline: 27 October 2019

Funding Type

PhD Type

The University of Plymouth’s Faculty of Health. Medicine, Dentistry & Human Sciences is seeking a highly motivated PhD candidate with outstanding abilities and enthusiasm for research.
  Health Opportunity for Patient Empowerment in Gestational Diabetes (HOPE-GDM)
  Research Group: Chemistry and Biosciences
  Prof A M Graham, Prof R Qahwaji, Prof A Locke
Applications accepted all year round

Funding Type

PhD Type

Gestational Diabetes is a temporary condition diagnosed at 24-28 weeks gestation, where the body is unable to maintain normal blood glucose levels due to insulin resistance during pregnancy.
  Impact of RhoA deregulation on smooth muscle cell phenotypic dysfunction in Type 2 diabetes
  Research Group: Chemistry and Biosciences
  Dr K Riches-Suman
Applications accepted all year round

Funding Type

PhD Type

Type 2 diabetes (T2D) is an escalating healthcare burden. It inflicts significant physical and emotional distress on patients and their carers, and treatment of T2D and its complications accounts for ~10% of the entire NHS budget.
  The generation of RBCs in vitro from stem cell sources and the molecular regulation of erythropoiesis in health and disease
  Dr J Frayne
Applications accepted all year round

Funding Type

PhD Type

Development of systems for the generation of red blood cells (RBCs) from stem cell sources (adult peripheral blood, cord blood and pluripotent stem cells)…
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
  Identification of novel glucose-dependent alterations responsible for platelet dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr F Rivero
Application Deadline: 31 March 2020

Funding Type

PhD Type

Type 2 diabetes mellitus (T2DM) is a growing global healthcare problem. Clinical findings suggest that more than 70% of patients with T2DM will die of cardiovascular diseases (CVDs) including heart attack and stroke.
  Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia
  Dr M Arman
Application Deadline: 31 March 2020

Funding Type

PhD Type

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.